Juan Pablo Sánchez Navarro

Dr. Juan Pablo Sánchez Navarro

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MAMauricio Alfredo Ambriz Alarcón
Mauricio Alfredo Ambriz Alarcón
DADaniel Iván Arroyo-Espinosa
Daniel Iván Arroyo-Espinosa
HMHéctor Meugniot-García
Héctor Meugniot-García
JNJuan Pablo Sánchez Navarro
Juan Pablo Sánchez Navarro
BRBrian Rafael Rubio-Mora
Brian Rafael Rubio-Mora
Enrique Cervantes-PérezEnrique Cervantes-Pérez
Enrique Cervantes-Pérez
The objective of the study was to describe the frequency of acute myocardial injury (AMI) assessed by high-sensitivity cardiac troponin I (hs-cTnI) levels and to determine the possible initial risk factors (related to the characteristics of the patient, the disease, and the initial management) in a population of adult patients with early sepsis (within the first 72 h of diagnosis) in a single tertiary hospital center in western Mexico. For the inferential statistics, the proportions of the categorical dichotomous variables were compared using the chi-square test. In all analyses, p values less than 0.05 with a 95% confidence interval were considered significant. We included a total of 64 patients diagnosed with early sepsis, of whom 46 presented elevated hs-cTnI and were classified as having AMI. In our study, the frequency of AMI in patients with early sepsis was 71.87%, and no significant differences were found in all of the characteristics of patients with early sepsis with and without AMI, nor was any significant association found with any of the variables analyzed. In the population of western Mexico, the frequency of AMI in patients with early sepsis, assessed by hs-cTnI levels, is high and similar to that reported in other populations worldwide.

Verified
Journal Article
Open access
PDF file
JMJOSE Antonio MATA MARIN
JOSE Antonio MATA MARIN
MAMarisol Apaez-Iglesias
Marisol Apaez-Iglesias
ADAna Luz Cano Díaz
Ana Luz Cano Díaz
JNJuan Pablo Sánchez Navarro
Juan Pablo Sánchez Navarro
DFDiana Edith Fernández-Madinaveitia
Diana Edith Fernández-Madinaveitia
JGJesus Enrique Gaytan-Martínez
Jesus Enrique Gaytan-Martínez
Background/Objectives: Patients with immune-mediated inflammatory diseases (IMIDs) treated with disease-modifying antirheumatic drugs (DMARDs) are at increased risk of latent tuberculosis infection (LTBI) reactivation, influenced by DMARD type. This study aimed to determine LTBI prevalence using interferon-gamma release assays (IGRAs) and identify associated risk factors in IMID patients in a middle-high TB burden setting in Mexico. Methods: A cross-sectional study was conducted from July 2024 to April 2025 at an IMID clinic. Patients aged ≥18 years, either receiving DMARDs or prior to initiating treatment, were included. LTBI was diagnosed using the QuantiFERON-TB Gold Plus assay. Bivariate analysis was performed using the chi-square test, and multivariate analysis was conducted. Results: LTBI prevalence was 34.2% (95% CI 29.1–39.7%) according to QFT-Plus and 35.6% (95% CI 29.7–42.0%) according to TSTs (n = 230). Prior TB exposure was the strongest risk factor (aOR 4.20, 95% CI 1.74–10.12, p = 0.001), while rheumatoid arthritis was associated with a lower LTBI likelihood (aOR 0.31, 95% CI 0.16–0.59, p < 0.001). Conclusions: A high prevalence of LTBI was observed in patients with IMIDs treated with DMARDs. Prior tuberculosis exposure was strongly associated with LTBI. These findings highlight the importance of LTBI screening in this population to prevent reactivation.

1 January 2025 in Journal of the International Association of Providers of AIDS Care (JIAPAC)
Verified
Journal Article
Open access
JNJuan Pablo Sánchez Navarro
Juan Pablo Sánchez Navarro
GAGustavo Barriga Angulo
Gustavo Barriga Angulo
JMJOSE Antonio MATA MARIN
JOSE Antonio MATA MARIN
MEMara Soraya Rodriguez Evaristo
Mara Soraya Rodriguez Evaristo
PNPaola Edith Padilla Noguera
Paola Edith Padilla Noguera
JMJesús Enrique Gaytán Martínez
Jesús Enrique Gaytán Martínez
Background: The incidence of sexually transmitted infections (STIs) remains high among men who have sex with men (MSM) living with human immunodeficiency virus (HIV) (PWH). This study determined the prevalence of asymptomatic STIs in MSM PWH attending an HIV clinic in Mexico City. Methods: This cross-sectional study (May 2022-November 2023) included self-questionnaires on STI-related behaviors and symptoms, urethral samples for multiplex polymerase chain reaction (PCR), and serological tests for syphilis, HBV, and HCV. Results: Among 261 patients, 56.7% were receiving antiretroviral therapy, 41.8% had suppressed HIV-1 viral load, and 26.1% tested positive for at least one STI in urethral PCR. The most prevalent microorganisms were Ureaplasma urealyticum (14.9%), Mycoplasma hominis (6.9%), Mycoplasma genitalium (4.2%), and Chlamydia trachomatis (3.1%). Multiple infections were identified in 5.3% of cases. Seroprevalence rates for syphilis, HBV, and HCV were 17.6%, 6.5%, and 3.1%, respectively. Current smoking and insertive anal sex were the only statistically significant associated factors. Conclusions: This study underscores the high frequency of asymptomatic STIs and the importance of regular screening.

19 September 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
Emily Itzel Pecero-GarcíaEmily Itzel Pecero-García
Emily Itzel Pecero-García
JDJuan Carlos Domínguez-Hermosillo
Juan Carlos Domínguez-Hermosillo
YPYessica Sara Pérez-González
Yessica Sara Pérez-González
JNJuan Pablo Sánchez Navarro
Juan Pablo Sánchez Navarro
MAMauricio Alfredo Ambriz Alarcón
Mauricio Alfredo Ambriz Alarcón
Enrique Cervantes-PérezEnrique Cervantes-Pérez
Enrique Cervantes-Pérez
Despite advances in the understanding of Kaposi sarcoma (KS), research from resource-limited settings remains limited. This study aimed to estimate the proportion of epidemic visceral KS among Mexican people living with HIV (PLHIV) and to describe their clinical and biochemical characteristics. We included PLHIV with histopathologically confirmed KS who received care at the National Medical Center La Raza between March 2020 and February 2023. We calculated the prevalence of epidemic KS and epidemic visceral KS and analyzed clinical and biochemical variables potentially associated with visceral involvement. The prevalence of epidemic KS was 5.6%. Among these cases, 51.4% had visceral involvement, yielding an overall prevalence of 2.8%. Patients with epidemic visceral KS exhibited significantly higher rates of oral mucosal involvement and lower hemoglobin levels compared with those without visceral disease. These findings highlight the substantial burden of epidemic visceral KS in this population and should be confirmed in future studies with larger cohorts and robust designs aimed at identifying clinical and biochemical predictors of visceral involvement.